Showing results (161-170 of 199) with videos related to

Sort By:
Pageof 20
Lung Cancer (Amsterdam, Netherlands)|June 3, 2020
Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer expertsM Früh, C M Panje, M Reck, et al.
Science Advances|September 26, 2020
Platform for micro-invasive membrane-free biochemical sampling of brain interstitial fluidRitu Raman, Erin B Rousseau, Michael Wade, et al.
Scientific Reports|May 18, 2022
Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platformM Morfouace, S Novello, A Stevovic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2017
A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroupsC R Lindsay, V Faugeroux, S Michiels, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
Circulating innate immune markers and outcomes in treatment-naïve advanced non-small cell lung cancer patientsM Charrier, L Mezquita, B Lueza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2017
Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNAJ Remon, C Caramella, C Jovelet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohortJ Mazières, F Barlesi, T Filleron, et al.
Oncogene|May 10, 2016
All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growthP H Nguyen, J Giraud, C Staedel, et al.
Diagnostic and Interventional Imaging|October 6, 2020
Radiofrequency ablation versus surgical resection for the treatment of oligometastatic lung diseaseL Tselikas, L Garzelli, O Mercier, et al.
ESMO Open|June 22, 2026
Sex-based differences in tolerability of developmental antibody-drug conjugates (ADCs) in non-small-cell lung cancer (NSCLC)C Parisi, M Banini, F Mantuano, et al.
Pageof 20